Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3499 Neoplasms 2740 Prostatic Neoplasms 1583 Colorectal Neoplasms 1248 Lung Neoplasms 1188 Motor Activity 766 Head and Neck Neoplasms 621 Pancreatic Neoplasms 601 Colonic Neoplasms 586 Uterine Cervical Neoplasms 567 Carcinoma, Non-Small-Cell Lung 560 Carcinoma, Hepatocellular 559 Rectal Neoplasms 516 Stomach Neoplasms 493 Brain Neoplasms 438 Anxiety Disorders 401 Ovarian Neoplasms 399 Pain 376 Esophageal Neoplasms 347 Polycystic Ovary Syndrome 341 Neoplasm Metastasis 340 Fatigue 324 Urinary Bladder Neoplasms 314 Precursor Cell Lymphoblastic Leukemia-Lymphoma 303 Melanoma 298 Depression 286 Multiple Myeloma 283 Endometrial Neoplasms 263 Lymphoma 258 Hematologic Neoplasms 251

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER × Estrogen Receptor-positive Breast Cancer × Clear all

NCT03768479 2018-12-11

PET

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Unknown

Estrogen Receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡